Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Trial of BOLD-100 Plus Doxorubicin in Advanced Soft Tissue Sarcomas

NCT07027423 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT07027423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07027423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Trial of BOLD-100 Plus Doxorubicin in Advanced Soft Tissue Sarcomas
Lead sponsor
University Health Network, Toronto
Phase
Phase 1
Overall status
Not yet recruiting
Start date
March 30, 2026
Completion date
January 29, 2027
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma, sarcoma, soft-tissue, sarcoma,soft tissue, sarcomas